کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3333329 | 1213307 | 2014 | 7 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Allogreffe de cellules souches hématopoïétiques dans l'amégacaryocytose congénitale
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم زیستی و بیوفناوری
ایمنی شناسی و میکروب شناسی
ایمونولوژی
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Congenital amegakaryocytic thrombocytopenia (CAMT) is a rare aetiology of central thrombocytopenia characterised by severe reduction or absence of megakaryocytes in the bone marrow. This disease is caused by mutations in the c-MPL gene encoding for the receptor of thrombopoietin (TPO). The clinical presentation is variable and can often be mistaken for foetal/neonatal alloimmune thrombocytopenia or idiopathic thrombocytopenic purpura. Because of treatment failure, a central thrombocytopenia is suspected. The diagnosis is made by the bone marrow examination, the dosage of TPO and identification of mutations in the c-MPL gene. The outcome is quickly pancytopenia. Description of four new single-center observations of patients treated for CAMT, who underwent allogeneic hematopoietic stem cell transplantation, allowed to focus on this disease and its therapeutic approach. According to the type of c-MPL mutations, a variable outcome has been discussed. Because of haemorrhagic risk and the possibility of a malignant evolution, a stem cell transplantation, being the only curative treatment, must be considered as soon as the diagnosis is established. Gene therapy might be an interesting future prospect.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Revue d'Oncologie Hématologie Pédiatrique - Volume 2, Issue 1, March 2014, Pages 39-45
Journal: Revue d'Oncologie Hématologie Pédiatrique - Volume 2, Issue 1, March 2014, Pages 39-45
نویسندگان
D. Meyran, S. Giraudier, B. Bruno, F. Mazingue, B. Nelken, E. de Berranger,